Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders June 30, 2022
CannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp. June 29, 2022